Residency · Residency · Interventional Radiology
Thoracic Fluid Drainage: Chest Tube and Pleural Catheter Placement
Overview
Image-guided thoracic drainage encompasses thoracentesis, small-bore chest tube placement, and tunneled pleural catheter insertion. Indications include pleural effusion, pneumothorax, empyema, and hemothorax. Performed under ultrasound and/or CT guidance with local anesthesia. Tunneled pleural catheters (e.g., PleurX) have changed the management paradigm for malignant effusions.
Pleural Effusion Evaluation
Classification
Transudative: CHF, cirrhosis, nephrotic syndrome, hypoalbuminemia. Exudative: malignancy, infection (parapneumonic/empyema), PE, autoimmune disease. Light's criteria for exudate (any one positive): Pleural protein / serum protein >0.5. Pleural LDH / serum LDH >0.6. Pleural LDH >2/3 upper limit of normal serum LDH.
Imaging Assessment
Ultrasound: first-line for pleural effusion characterization and guidance. Simple effusion: anechoic. Complex effusion: septations, debris, echogenic material. Estimates volume and identifies optimal drainage site. CT with contrast: characterizes underlying cause, identifies loculations, pleural enhancement (suggests empyema or malignancy), and lung parenchymal disease.
Thoracentesis
Technique
Diagnostic (small volume, 50-100 mL) or therapeutic (large volume, 1-2 L). Ultrasound-guided: identify deepest fluid pocket, mark site, avoid diaphragm and solid organs. Patient seated upright, leaning forward over a table. 18-gauge needle or catheter-over-needle advanced under real-time ultrasound guidance. Aspirate and send for: cell count, protein, LDH, glucose, pH, cytology, culture, Gram stain. Large-volume thoracentesis: limit to 1-1.5 L per session (re-expansion pulmonary edema risk). Use vacuum bottle drainage systems for efficiency.
Complications
Pneumothorax (2-5% without ultrasound guidance; <1% with ultrasound). Re-expansion pulmonary edema (rare, with rapid drainage of large chronic effusions). Hemorrhage (intercostal vessel injury, splenic/hepatic laceration). Vasovagal reaction.
<image>Ultrasound image showing a large left-sided pleural effusion with the diaphragm and compressed lung visible, with planned needle insertion site marked for thoracentesis</image>
Small-Bore Chest Tube Placement
Indications
Moderate to large pleural effusion requiring continuous drainage. Pneumothorax (spontaneous, iatrogenic, or traumatic). Parapneumonic effusion or empyema. Hemothorax (small-bore for minor; large-bore for significant hemothorax).
Technique
Seldinger technique under ultrasound or CT guidance. Catheter sizes: 8-14 Fr pigtail catheters (most common in IR). Access: safe triangle (anterior border of latissimus dorsi, lateral border of pectoralis major, line superior to horizontal level of nipple, apex of axilla). Steps: Ultrasound localization of fluid/air. Local anesthesia (including intercostal periosteum). Needle insertion over the superior rib margin (avoid intercostal neurovascular bundle on inferior margin). Aspirate fluid/air to confirm position. Advance guidewire, dilate, place pigtail catheter. Secure catheter; connect to underwater seal or drainage system. Confirm position with chest radiograph.
Small-Bore vs. Large-Bore
Small-bore (≤14 Fr): adequate for most effusions and pneumothoraces. BTS guidelines: small-bore catheters are first-line for most indications. Large-bore (≥20 Fr): consider for significant hemothorax, large air leaks, or thick empyema. Small-bore advantages: less pain, easier insertion, fewer complications. Small-bore limitations: may occlude with thick fluid or clot.
Empyema Management
Complicated parapneumonic effusion and empyema often require: Small-bore chest tube + intrapleural fibrinolytic therapy (tPA + DNase). MIST2 trial protocol: tPA 10 mg + DNase 5 mg instilled intrapleurally, clamped for 1 hour, then drained; twice daily for 3 days. Significantly reduces need for surgery compared with saline alone. Alternative: VATS (video-assisted thoracoscopic surgery) for multiloculated empyema. Surgical decortication for organizing empyema (fibrinopurulent or organized stage).
<image>Chest radiograph showing a small-bore pigtail chest tube in the left hemithorax with near-complete drainage of a previously large parapneumonic effusion</image>
Tunneled Pleural Catheter (TPC)
Indications
Recurrent symptomatic malignant pleural effusion. Recurrent non-malignant effusion refractory to medical therapy (hepatic hydrothorax, CHF). Trapped lung (lung cannot re-expand due to visceral pleural thickening). Patient preference for home drainage over hospitalization.
PleurX / Aspira System
Silicone catheter with a polyester cuff (promotes tissue ingrowth for securement). Tunneled subcutaneously (reduces infection risk). One-way valve prevents air entry. Drained at home by patient/caregiver using vacuum bottles. Standard drainage schedule: every 1-2 days, 500-1000 mL per session.
Placement Technique
Ultrasound localization of effusion; mark optimal insertion site. Local anesthesia to skin, subcutaneous tissue, and pleural space. Create subcutaneous tunnel (5-10 cm from entry site to pleural space). Seldinger access into pleural space; guidewire and peel-away sheath placement. Thread tunneled catheter through subcutaneous tunnel; advance through peel-away sheath into pleural space. Remove peel-away sheath; position polyester cuff within tunnel (1-2 cm from skin exit). Aspirate effusion to confirm function. Secure with suture and dressing.
Spontaneous Pleurodesis
Occurs in 40-60% of malignant effusion patients with TPC. Defined as: daily drainage <50 mL for 3 consecutive drainages. Catheter can be removed once pleurodesis confirmed. Mechanism: chronic drainage → apposition of visceral and pleural surfaces → inflammation → fibrosis. Does NOT occur in trapped lung (visceral and parietal pleura cannot appose).
Controversy: TPC vs. Chemical Pleurodesis
| Feature | Chemical Pleurodesis (Talc) | Tunneled Pleural Catheter |
|---|---|---|
| Setting | Inpatient (3-7 days) | Outpatient |
| Success rate | 70-80% | Symptom relief >90% |
| Trapped lung | Contraindicated | Effective |
| Spontaneous pleurodesis | N/A (immediate) | 40-60% over time |
| Ongoing maintenance | None if successful | Home drainage required |
| Infection risk | Low | 3-5% |
| Key trial | TIME-2, IPC-Plus | TIME-2, AMPLE-2 |
| Best candidate | Expandable lung, limited survival | Trapped lung, patient preference |
Chemical Pleurodesis (Talc)
Talc slurry via chest tube or talc poudrage via VATS. Success rate: 70-80% for malignant effusions. Requires hospitalization (3-7 days). Requires lung re-expansion (trapped lung is a contraindication). Complications: pain, fever, ARDS (rare with graded talc).
Tunneled Pleural Catheter
Outpatient procedure; immediate symptom relief. Effective even with trapped lung. Avoids hospitalization for pleurodesis. Catheter-related complications: infection (3-5%), catheter obstruction, dislodgement. Ongoing maintenance required (home drainage, supplies).
Current Evidence
TIME-2 trial: TPC vs. talc pleurodesis — similar dyspnea relief at 6 months; TPC had fewer hospital days. AMPLE-2 trial: TPC with daily drainage → higher pleurodesis rates. Combination approaches: TPC + talc instillation through the catheter (IPC-Plus trial showed higher pleurodesis rate). Choice depends on: lung expansion status, expected survival, patient preference, ability to manage catheter at home.
<image>Tunneled pleural catheter (PleurX) placement showing the subcutaneous tunnel with the polyester cuff positioned within the tunnel and the catheter tip in the pleural space with the external drainage connection</image>
Complications
Chest Tube / TPC
Catheter malposition. Infection (empyema from chest tube 1-2%; TPC infection 3-5%). Catheter obstruction. Intercostal vessel injury / hemorrhage. Organ injury (liver, spleen, diaphragm). Tumor seeding along catheter tract (rare). Catheter fracture or dislodgement. Subcutaneous emphysema.
Pleural-Specific
Re-expansion pulmonary edema (drain slowly; limit initial drainage). Sympathetic effusion (contralateral after pleurodesis). Loculated effusion (may require fibrinolytic therapy or additional catheter).
Clinical Pearls
Always use ultrasound guidance for thoracentesis and chest tube placement — it reduces pneumothorax risk from 5% to <1% and improves first-pass success. The intercostal neurovascular bundle runs along the inferior rib margin — always insert the needle/catheter over the superior margin of the rib. For malignant effusions, assess for trapped lung (failure to re-expand after initial drainage) — this dictates whether pleurodesis is feasible or if a tunneled catheter is the better option. The MIST2 protocol (tPA + DNase) has revolutionized empyema management — it significantly reduces surgical referrals for parapneumonic collections. Re-expansion pulmonary edema risk increases with effusions present >3 days and volumes >1.5 L drained rapidly; stop drainage if the patient develops chest tightness or cough. Tunneled pleural catheters achieve spontaneous pleurodesis in ~50% of patients — counsel patients that the catheter may be temporary rather than permanent. For hepatic hydrothorax, a tunneled pleural catheter can improve quality of life, but watch for protein and electrolyte depletion with large daily drainage volumes. When placing a chest tube for pneumothorax, aim for the apex of the hemithorax; for fluid, aim posteriorly and inferiorly.
References
- Davies HE, et al. Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Malignant Pleural Effusion (TIME2 Trial). JAMA. 2012;307(22):2383-2389.
- Rahman NM, et al. Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection (MIST2 Trial). N Engl J Med. 2011;365(6):518-526.
- Defined BTS Guidelines for Pleural Disease. Thorax. 2010;65(Suppl 2):ii54-ii60.
- Defined TJ, et al. Tunneled Pleural Catheters for Malignant Pleural Effusions: Review. J Vasc Interv Radiol. 2017;28(4):483-491.
- Thomas R, et al. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis (IPC-Plus Trial). JAMA. 2017;318(19):1903-1912.
How to think about this
Interventional Radiology plays a crucial role in managing thoracic fluid collections, from diagnostic sampling to complex drainage procedures. Understanding the nuances between thoracentesis, small-bore chest tube placement, and tunneled pleural catheters (TPC) is key to providing appropriate care. The choice of procedure hinges on the fluid characteristics (transudative vs. exudative, simple vs. loculated), the underlying etiology (malignancy, infection), and the patient's clinical status and prognosis. Modern approaches emphasize image guidance for safety and efficacy, and small-bore catheters are now the first-line for many indications, reducing patient discomfort and complications compared to their larger counterparts. Furthermore, the advent of TPCs has revolutionized the outpatient management of recurrent effusions, significantly improving quality of life.
Check yourself with 2 bullets.
- What are Light's criteria for exudative effusions, and why is imaging essential for characterizing pleural effusions beyond simple presence?
- Compare and contrast the indications and contraindications for chemical pleurodesis versus tunneled pleural catheter placement in the management of recurrent malignant pleural effusions.
